دورية أكاديمية
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center
| العنوان: | Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center |
|---|---|
| المؤلفون: | Othman, Tamer, Moskoff, Benjamin N., Ho, Gwendolyn, Tenold, Matthew E., Azenkot, Tali, Krackeler, Margaret L., Fisch, Samantha C., Potter, Laura A., Kaesberg, Paul R., Welborn, Jeanna L., Wun, Ted, Esteghamat, Naseem S., Hoeg, Rasmus T., Rosenberg, Aaron S., Abedi, Mehrdad, Tuscano, Joseph M., Jonas, Brian A. |
| المساهمون: | NIH |
| المصدر: | Leukemia Research ; volume 119, page 106885 ; ISSN 0145-2126 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.leukres.2022.106885 |
| الإتاحة: | https://doi.org/10.1016/j.leukres.2022.106885Test https://api.elsevier.com/content/article/PII:S0145212622001114?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0145212622001114?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.3BF86F14 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.leukres.2022.106885 |
|---|